Knight Jeff E. bought CRNX
February 23, 2026 · Form 4 insider transaction
Knight Jeff E. bought 34,000 shares of Crinetics Pharmaceuticals Inc at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
34,000
Price
$0.00
Total value
N/A
InsiderKnight Jeff E.
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 23, 2026
Filing dateFebruary 25, 2026
Shares owned after121,929
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The transaction reported on this line involves the receipt of restricted stock units, which represent the right to receive shares of the Issuer's Common Stock, with 25% vesting annually beginning on March 1, 2027.; Includes 438 shares acquired under the Issuer's Employee Stock Purchase Plan.